1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Acurx Pharmaceuticals Inc (ACXP)
  7. Financials

ACXP

Acurx Pharmaceuticals Inc
3.21
0.00 (0.00%)
Upgrade to Real-Time

Acurx Pharmaceuticals Inc. (ACXP) Fundamentals
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
SHARE INFORMATION
Market CapUS$ 37,350,902
Shares Outstanding11,635,795
Float9,239,594
Percent Float79.41%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -1.12
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions29
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months99,776
Institutional Holdings Percent13.8%
Institutional Sold Previous 3 Months186,000
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months335,000
Insider Holdings Percent20.6
Insider Sold Previous 3 Months-
Insider Shares Owned2,390,713
TRADING INFO
52 Week HighUS$ 4.85
52 Week LowUS$ 2.33
52 Week High ChangeUS$ -5.59
21 Day Moving AverageUS$ 3.3595
21 Day Extended Moving AverageUS$ 3.3683
50 Day Moving AverageUS$ 3.6024
50 Day Extended Moving AverageUS$ 3.4954
200 Day Moving AverageUS$ 3.5583
200 Day Extended Moving AverageUS$ 3.6105
10 Day Average Volume35,983
20 Day Average Volume35,804
30 Day Average Volume35,025
50 Day Average Volume37,711
Alpha-0.024772
Beta-0.9225
Standard Deviation0.147804
R20.135605
7 Day Price ChangeUS$ -0.20
7 Day Percent Change-5.87%
21 Day Price ChangeUS$ -0.09
21 Day Percent Change-2.73%
30 Day Price ChangeUS$ 0.01
30 Day Percent Change0.31%
Month to Date Price ChangeUS$ -0.10
Month to Date Percent Change-3.02%
Quarter to Date Price ChangeUS$ -0.77
Quarter to Date Percent Change-19.35%
180 Day Price ChangeUS$ -0.10
180 Day Percent Change-3.02%
200 Day Price ChangeUS$ -0.17
200 Day Percent Change-5.03%
Year to Date Price ChangeUS$ -0.77
Year to Date Percent Change-19.35%

Acurx Pharmaceuticals Inc. (ACXP) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.00
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio4.50
Leverage Ratio1.10
Quick Ratio4.40
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-3.10
Enterprise ValueUS$ 33,974,626
Price to Sales0.00
Price to Free Cash-4.80
PE High Last 5 Years0.00
Price To Book5.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book5.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-110.54
Return on Equity-127.15
Return on Capital-95.33

Acurx Pharmaceuticals Inc. (ACXP) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorCohnReznick LLP
CEODavid P. Luci
Emplyoees3
Last AuditUE
CIK0001736243
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address259 Liberty Avenue
Staten Island, NY 10305
Websitehttps://www.acurxpharma.com
Facsimile-
Telephone+1 917 533-1469
Email-
Your Recent History
NASDAQ
ACXP
Acurx Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230323 14:47:18